Loading clinical trials...
Loading clinical trials...
Assessment of Symptomatic and Incidental Detection of Renal Cell Carcinoma Using Standard Imaging Modalities
Evaluation of the frequency of symptomatic and incidental detection of renal carcinoma at different stages depending on the imaging modality used
In the Czech Republic, there is no screening program for renal cell carcinoma. Existing evidence suggests that incidental detection of this cancer tends to occur in its early stages, which are more manageable due to effective treatment options, ultimately reducing renal cancer mortality. This highlights the potential value of evaluating current imaging modalities and determining their role in secondary prevention. This cross-sectional study, based on hospital data, aims to contribute to a better understanding of this issue and to assess the effectiveness of imaging techniques in the early detection of renal cell carcinoma. Furthermore, data analysis may reveal the influence of risk factors on the detection of tumors at various stages.
Age
18 - 90 years
Sex
ALL
Healthy Volunteers
No
University Hospital Královské Vinohrady
Prague, Czechia
Start Date
June 1, 2025
Primary Completion Date
July 1, 2025
Completion Date
July 15, 2025
Last Updated
March 19, 2026
1,000
ACTUAL participants
Surgical treatment of renal lesions
PROCEDURE
Lead Sponsor
Charles University, Czech Republic
Collaborators
NCT07485114
NCT05665361
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions